John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Marcus & Millichap
MMI
$1.23B
| $278K | ﹤0.01% |
8,065
+2,065
| +34% | +$76K |
|
|
CLPR
2677
Clipper Realty
CLPR
$55.4M
| $278K | ﹤0.01% |
72,340
+49,845
| +222% | +$209K |
|
2678
Protagonist Therapeutics
PTGX
$10B
| $278K | ﹤0.01% |
5,741
+83
| +1% | +$3.48K |
|
2679
JELD-WEN Holding
JELD
$216M
| $276K | ﹤0.01% |
+46,291
| New | +$344K |
|
2680
Waterstone Financial
WSBF
$381M
| $276K | ﹤0.01% |
20,540
-3,935
| -16% | -$53.6K |
|
2681
Neumora Therapeutics
NMRA
$287M
| $274K | ﹤0.01% |
274,314
+226,024
| +468% | +$387K |
|
2682
TMC The Metals Company
TMC
$2.09B
| $274K | ﹤0.01% |
+159,131
| New | +$267K |
|
2683
Laird Superfood
LSF
$42.2M
| $273K | ﹤0.01% |
44,441
-23,696
| -35% | -$160K |
|
|
TGB
2684
Trekor Metals
TGB
$3.42B
| $270K | ﹤0.01% |
120,664
-878,096
| -88% | -$1.86M |
|
2685
Kadant
KAI
$3.69B
| $270K | ﹤0.01% |
800
-393
| -33% | -$143K |
|
2686
TFS Financial
TFSL
$4.95B
| $268K | ﹤0.01% |
+21,664
| New | +$277K |
|
2687
Daktronics
DAKT
$918M
| $268K | ﹤0.01% |
22,016
+9,316
| +73% | +$141K |
|
2688
Silicon Laboratories
SLAB
$7.28B
| $266K | ﹤0.01% |
+2,363
| New | +$319K |
|
|
SNBR
2689
DELISTED
Sleep Number
SNBR
| $266K | ﹤0.01% |
41,880
-68,101
| -62% | -$911K |
|
|
PR
2690
Permian Resources
PR
$19.8B
| $265K | ﹤0.01% |
19,130
-13,900
| -42% | -$199K |
|
|
NAGE
2691
Niagen Bioscience
NAGE
$254M
| $265K | ﹤0.01% |
38,393
-88,905
| -70% | -$559K |
|
|
ZYXI
2692
DELISTED
Zynex
ZYXI
| $264K | ﹤0.01% |
120,183
+38,089
| +46% | +$249K |
|
|
WOW
2693
DELISTED
WideOpenWest
WOW
| $264K | ﹤0.01% |
53,327
-84,412
| -61% | -$388K |
|
2694
Alector
ALEC
$257M
| $264K | ﹤0.01% |
214,425
-193,564
| -47% | -$315K |
|
|
ALAR
2695
Alarum Technologies
ALAR
$12.5M
| $263K | ﹤0.01% |
42,101
+29,122
| +224% | +$253K |
|
2696
Simply Good Foods
SMPL
$970M
| $263K | ﹤0.01% |
+7,624
| New | +$276K |
|
2697
Sensata Technologies
ST
$6.11B
| $262K | ﹤0.01% |
10,803
-86,421
| -89% | -$2.39M |
|
|
PVBC
2698
DELISTED
Provident Bancorp
PVBC
| $261K | ﹤0.01% |
22,761
-2,361
| -9% | -$27.6K |
|
2699
BJ's Restaurants
BJRI
$1.43B
| $261K | ﹤0.01% |
7,623
-18,772
| -71% | -$666K |
|
2700
ABM Industries
ABM
$2.75B
| $261K | ﹤0.01% |
5,514
-16,614
| -75% | -$855K |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.